Tag Archive: drug industry

May 25 2012

PDUFA V: A Funny Sounding Name for a Very Important Bill (Updated!)

US Capitol

Can you say PDUFA (pŭ-dōō-fŭ)?  The United States Senate can.  A very partisan Senate showed uncharacteristically bipartisan support for the Prescription Drug and User Fee Act (PDUFA) V, voting on 24 May 2012 to reauthorize PDUFA by a 96 to 1 vote.  This reauthorization allows for a 6% increase in fees paid by drug and …

Continue reading »

Feb 23 2012

The CED Life Science Conference and Biotech’s Yellow Brick Road

The 21st annual CED Life Science Conference achieved its mission of cementing the Research Triangle Park as a hotbed for innovation and opportunity in biotech.  The 2012 CED LSC showcased local leaders like Victor Dzau, President and CEO of Duke University Health Systems, and former four-term North Carolina governor James B. Hunt, as well as …

Continue reading »

Apr 26 2010

Pharma’s Looming Cash Flow Crunch

Our greatest lack is not money for any undertaking, but rather ideas.  If the ideas are good, cash will somehow flow to where it is needed. – Robert H. Schuller Pharmalot posted a quick summary of a report by Moody’s Investor Service that compares aggregate drug industry debt from 2006 to 2009.  As usual, I …

Continue reading »